| 1 | 328543-09-5 | AG14361 | AG14361 | C19H20N4O
| DNA损伤;小分子抑制剂，天然产物 | |
| 2 | 882256-55-5 | iGOT1-01 | iGOT1-01 | C19H20N4O
| | |
| 3 | 1038915-60-4 | 尼拉帕尼 | Niraparib | C19H20N4O
| 中间体 - 医药中间体 | |
| 4 | 1038915-75-1 | 2-(4-(哌啶-3-基)苯基)-2H-吲唑-7-甲酰胺 | MK-4827 (RaceMate) | C19H20N4O
| | |
| 5 | 1038915-58-0 | MK-4827 (R-enantioMer) | MK-4827 (R-enantioMer) | C19H20N4O
| | |
| 6 | 39213-14-4 | 5-25-13-00126 (Beilstein Handbook Reference) | 5-25-13-00126 (Beilstein Handbook Reference) | C19H20N4O
| | |
| 7 | | 2-[4-Benzyl-1-piperazinyl]quinazolin-4(3H)-one | 2-[4-Benzyl-1-piperazinyl]quinazolin-4(3H)-one | C19H20N4O
| | |
| 8 | | 2-[4-Methyl-1-piperazinyl]-4-(phenoxy)quinazoline | 2-[4-Methyl-1-piperazinyl]-4-(phenoxy)quinazoline | C19H20N4O
| | |
| 9 | 220998-76-5 | 4-[(4-PHENYLPIPERAZINO)METHYL]-1(2H)-PHTHALAZINONE | 4-[(4-PHENYLPIPERAZINO)METHYL]-1(2H)-PHTHALAZINONE | C19H20N4O
| | |
| 10 | | N1-phenyl-4-(1H-indol-4-yl)piperazine-1-carboxamide | N1-phenyl-4-(1H-indol-4-yl)piperazine-1-carboxamide | C19H20N4O
| | |
| 11 | | 4-(1H-Imidazol-1-yl)-N-(2-benzylaminoethyl)benzamide | 4-(1H-Imidazol-1-yl)-N-(2-benzylaminoethyl)benzamide | C19H20N4O
| | |
| 12 | 13071-15-3 | | 8-Quinolinol, 5-[2-[4-(diethylamino)phenyl]diazenyl]- | C19H20N4O
| | |
| 13 | 850379-78-1 | N-(4-tert-butylphenyl)-6-(1H-pyrazol-1-yl)nicotinamide | N-(4-tert-butylphenyl)-6-(1H-pyrazol-1-yl)nicotinamide | C19H20N4O
| | |
| 14 | 306979-88-4 | 5-ACETYL-6-METHYL-2-(4-PHENYLPIPERAZINO)NICOTINONITRILE | 5-ACETYL-6-METHYL-2-(4-PHENYLPIPERAZINO)NICOTINONITRILE | C19H20N4O
| | |
| 15 | | 1-(4-METHYLBENZYL)-5-P-TOLYL-1H-PYRAZOLE-3-CARBOHYDRAZIDE | 1-(4-METHYLBENZYL)-5-P-TOLYL-1H-PYRAZOLE-3-CARBOHYDRAZIDE | C19H20N4O
| | |
| 16 | 1038915-64-8 | 甲苯磺酸尼拉帕利 | (S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxaMide | C19H20N4O
| 医药原料;化工中间体;3-取代哌啶 | |
| 17 | 1034736-11-2 | N-mesityl-5-methyl-1-phenyl-1H-1,2,3-triazole-4-carboxamide | N-mesityl-5-methyl-1-phenyl-1H-1,2,3-triazole-4-carboxamide | C19H20N4O
| | |
| 18 | 303204-03-7 | 3-[(4-benzyl-1-piperazinyl)imino]-1,3-dihydro-2H-indol-2-one | 3-[(4-benzyl-1-piperazinyl)imino]-1,3-dihydro-2H-indol-2-one | C19H20N4O
| | |
| 19 | 279216-08-9 | (6-((bis(pyridin-2-ylmethyl)amino)methyl)pyridin-2-yl)methanol | (6-((bis(pyridin-2-ylmethyl)amino)methyl)pyridin-2-yl)methanol | C19H20N4O
| | |
| 20 | | N-(2-(dimethylamino)ethyl)-2-(4-pyridyl)quinoline-8-carboxamide | N-(2-(dimethylamino)ethyl)-2-(4-pyridyl)quinoline-8-carboxamide | C19H20N4O
| | |
| 21 | 86589-81-3 | 1-苄基-4-[3-(3,4-二氢-4-氧代-1,2,3-苯并三嗪)基]哌啶 | 1-Benzyl-4-(3,4-dihydro-4-oxo-1,2,3-benzotriazin-3-yl)piperidine | C19H20N4O
| | |
| 22 | 924833-33-0 | 1-(2,6-dimethylphenyl)-N,5-dimethyl-N-phenyltriazole-4-carboxamide | 1-(2,6-dimethylphenyl)-N,5-dimethyl-N-phenyltriazole-4-carboxamide | C19H20N4O
| | |
| 23 | 1785765-14-1 | {1-[1-(二苯甲基)氮杂环丁烷-3-基]-1H-1,2,3-三唑-4-基}甲醇 | {1-[1-(diphenylmethyl)azetidin-3-yl]-1H-1,2,3-triazol-4-yl}methanol | C19H20N4O
| | |
| 24 | | 3-([2-METHYL-6-(5-PHENYLPYRIDIN-3-YL)PYRIMIDIN-4-YL]AMINO)PROPAN-1-OL | 3-([2-METHYL-6-(5-PHENYLPYRIDIN-3-YL)PYRIMIDIN-4-YL]AMINO)PROPAN-1-OL | C19H20N4O
| | |
| 25 | | 2-([7-OXO-4-(PYRIDIN-3-YLMETHYL)-1,4-DIAZEPAN-1-YL]METHYL)BENZONITRILE | 2-([7-OXO-4-(PYRIDIN-3-YLMETHYL)-1,4-DIAZEPAN-1-YL]METHYL)BENZONITRILE | C19H20N4O
| | |
| 26 | 1034736-23-6 | N-(3-isopropylphenyl)-5-methyl-1-phenyl-1H-1,2,3-triazole-4-carboxamide | N-(3-isopropylphenyl)-5-methyl-1-phenyl-1H-1,2,3-triazole-4-carboxamide | C19H20N4O
| | |
| 27 | 1034735-40-4 | N-(4-isopropylphenyl)-1-(4-methylphenyl)-1H-1,2,4-triazole-3-carboxamide | N-(4-isopropylphenyl)-1-(4-methylphenyl)-1H-1,2,4-triazole-3-carboxamide | C19H20N4O
| | |
| 28 | | 3-[(4,6-DIMETHYLPYRIMIDIN-2-YL)OXY]-N-METHYL-N-PHENYL-2-PYRIDINEMETHANAMINE | 3-[(4,6-DIMETHYLPYRIMIDIN-2-YL)OXY]-N-METHYL-N-PHENYL-2-PYRIDINEMETHANAMINE | C19H20N4O
| | |
| 29 | 305333-00-0 | 2-ethyl-3-methyl-1-(morpholin-4-yl)pyrido[1,2-a]benzimidazole-4-carbonitrile | 2-ethyl-3-methyl-1-(morpholin-4-yl)pyrido[1,2-a]benzimidazole-4-carbonitrile | C19H20N4O
| | |
| 30 | 886230-76-8 | (E)-3-[2-(吡啶-2-基)乙烯基]-1-(四氢-2H-吡喃-2-基)-1H-吲唑-6-胺 | (E)-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-amine | C19H20N4O
| 医药中间体;阿西替尼中间体 | |
| 31 | 1285638-73-4 | (E)-3-isopropyl-N-(1-(naphthalen-1-yl)ethylidene)-1H-pyrazole-5-carbohydrazide | (E)-3-isopropyl-N-(1-(naphthalen-1-yl)ethylidene)-1H-pyrazole-5-carbohydrazide | C19H20N4O
| | |
| 32 | 1034735-18-6 | N-(2,4-dimethylphenyl)-N-methyl-1-(4-methylphenyl)-1H-1,2,4-triazole-3-carboxamide | N-(2,4-dimethylphenyl)-N-methyl-1-(4-methylphenyl)-1H-1,2,4-triazole-3-carboxamide | C19H20N4O
| | |
| 33 | | 1-(4-{[4-(dimethylamino)benzylidene]amino}phenyl)-3-methyl-4,5-dihydro-1H-pyrazol-5-one | 1-(4-{[4-(dimethylamino)benzylidene]amino}phenyl)-3-methyl-4,5-dihydro-1H-pyrazol-5-one | C19H20N4O
| | |
| 34 | 340811-36-1 | 6-amino-5-cyano-3-methyl-2,4-dihydro-1'-phenylspiro[pyrano[2,3-c]pyrazole-4,4'-cyclohaxane] | 6-amino-5-cyano-3-methyl-2,4-dihydro-1'-phenylspiro[pyrano[2,3-c]pyrazole-4,4'-cyclohaxane] | C19H20N4O
| | |
| 35 | 76132-30-4 | 9,9-二甲基-6-(3-吡啶基)-6,8,10,11-四氢-5H-吡啶并[3,2-B][1,4]苯并二氮杂卓-7-酮 | 7,7-Dimethyl-10-pyridin-3-yl-5,6,7,8,10,11-hexahydro-9H-pyrido[3,2-b][1,4]benzodiazepin-9-one | C19H20N4O
| | |
| 36 | 304012-25-7 | 4-methyl-6,7-dihydrospiro(benzo[h][1,2,4]triazolo[4,3-a]quinazoline-6,1'-cyclohexane)-5(4H)-one | 4-methyl-6,7-dihydrospiro(benzo[h][1,2,4]triazolo[4,3-a]quinazoline-6,1'-cyclohexane)-5(4H)-one | C19H20N4O
| | |
| 37 | 2719751-28-5 | 1H-Pyrrolo[2,3-b]pyridine-3-carbonitrile, 2-amino-1-(3-methoxy-2,6-dimethylphenyl)-5,6-dimethyl- | 1H-Pyrrolo[2,3-b]pyridine-3-carbonitrile, 2-amino-1-(3-methoxy-2,6-dimethylphenyl)-5,6-dimethyl- | C19H20N4O
| | |
| 38 | 612523-20-3 | 11-((2-methoxyethyl)amino)-7,8,9,10-tetrahydrobenzo[4,5]imidazo[1,2-b]isoquinoline-6-carbonitrile | 11-((2-methoxyethyl)amino)-7,8,9,10-tetrahydrobenzo[4,5]imidazo[1,2-b]isoquinoline-6-carbonitrile | C19H20N4O
| | |